Loading...
NPI 1447783923 · Ocala, FL · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Labs Asap LLC is a clinical medical laboratory provider located in Ocala, Florida. This profile covers 48 Medicare and 96 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Labs Asap LLC |
| Address | 1601 Ne 25th Ave. Unit 103 |
| City | Ocala |
| State | FL |
| ZIP | 34470 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 11, 2017 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4.1M |
| Medicaid | $2.9M |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
48 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 57,440 | $30 | $2M |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 12,940 | $30 | $439.9K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 1,520 | $240 | $367.6K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 1,100 | $140 | $154.3K |
| 87181 | The lab analyst performs the technical steps to evaluate a culture isolate’s susceptibility, or sensitivity, to a specific antimicrobial agent, commonly called an antibiotic. He uses a test device… | 24,350 | $10 | $121.7K |
| 87653 | The lab analyst performs a test for Streptococcus, group B, using amplified nucleic acid probe technique. The amplified probe provides a rapid means to assess colonization by Streptococcus, group B,… | 3,460 | $30 | $117.7K |
| 87563 | he lab analyst performs a test on a patient specimen such as blood, for Mycoplasma genitalium antigen detection using amplified nucleic acid probe technique. | 3,450 | $30 | $117.3K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 1,470 | $70 | $108.6K |
| 87641 | The lab analyst performs a test for methicillin–resistant Staphylococcus aureus (MRSA) using an amplified nucleic acid probe technique. | 2,680 | $30 | $91.3K |
| 87500 | The lab analyst performs a test for vancomycin resistance in an infectious organism’s nucleic acid using amplified probe technique. VRE, vancomycin resistant enterococcus, is the most common organism… | 2,680 | $30 | $91.1K |
Showing 1–10 of 48
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 48 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
48 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 2 | 110 | 590 | $30 | $218.6K |
| 81513 | 11 | 10 | 400 | $140 | $99.1K |
| 87481 | 3 | 80 | 340 | $30 | $72.8K |
| 87511 | 10 | 10 | 220 | $30 | $60.4K |
| G0483 | 4 | 100 | 90 | $240 | $55.9K |
| U0003 | 10 | 50 | 190 | $70 | $47.1K |
| G0482 | 32 | 210 | 80 | $190 | $31.8K |
| 87640 | 4 | 70 | 210 | $30 | $30.9K |
| 87653 | 3 | 70 | 180 | $30 | $30.8K |
| 87500 | 3 | 70 | 190 | $30 | $29.6K |
Showing 1–10 of 48
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
96 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 19,570 | $40 | $821.8K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 9,710 | $50 | $446.7K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 8,440 | $20 | $202.6K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 620 | $230 | $142.2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 18,470 | $1 | $73.9K |
| 80323 | The lab analyst identifies and evaluates the level of alkaloid drugs in a patient specimen that are not specified elsewhere in CPT® by a different code from the class of alkaloids. | 8,750 | $10 | $61.2K |
| 80346 | The lab analyst measures the amount of or detects the presence of one to twelve benzodiazepines, which are tranquilizers, in a patient specimen. | 3,520 | $20 | $59.9K |
| 87631 | The lab analyst performs the technical steps to detect three to five types or subtypes of pathogens, such as adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,… | 1,630 | $30 | $52.1K |
| 80334 | The lab analyst measures the amount of or detects the presence of six or more serotonergic antidepressants, which are psychiatric medications, in a patient specimen. | 7,400 | $10 | $51.8K |
| 87481 | The lab analyst performs a test for Candida species using amplified nucleic acid probe technique. | 5,680 | $10 | $51.1K |
Showing 1–10 of 96
How this provider's Medicaid billing volume and revenue compare to other Florida providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Florida median
96 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 17 | 20 | 130 | $210 | $1.5M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 12 | 40 | 320 | $100 | $620K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 21 | 320 | 750 | $40 | $232.7K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 509 | 640 | 4,400 | $10 | $193.4K |
| 81513 | The lab analyst performs the technical lab test on a vaginal fluid specimen for quantitative real–time amplification of RNA markers for three bacterial species listed in the code descriptor, and… | 16 | 20 | 100 | $60 | $156K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 70 | 160 | 450 | $50 | $115.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 129 | 340 | 720 | $10 | $100.6K |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 48 | 50 | 360 | $40 | $96.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 599 | 820 | 1,430 | $1 | $92.8K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 17 | 80 | 240 | $10 | $92.2K |
Showing 1–10 of 96
Other providers in the same ZIP code as Labs Asap LLC, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Quad Nurse LLC | FL | Attendant Care Provider | $0 | $7.8M |
| Metro Treatment Of Florida, LP | FL | Methadone Clinic | $158.6K | $5.7M |
| Doyle Phillips | FL | Family Medicine Physician | $239.5K | $0 |
| Carl Salvati | FL | Foot & Ankle Surgery Podiatrist | $209.7K | $0 |
| Aileen Lamela | FL | Optometrist | $44K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.